Patient guide

Follow-up after BCC and cSCC

Follow-up is not only about the scar. The risk of additional skin cancers is increased, while higher-risk cSCC also requires attention to regional nodes.

What follow-up is actually looking for

BCC

Focus on local recurrence and additional skin cancers.

Higher-risk cSCC

Scar + regional nodes + imaging in selected patients.

Self-check

Show new non-healing, bleeding or rapidly growing lesions early.

What to check

  • the scar and surrounding skin;
  • new nodules, ulcers, bleeding or crusted lesions;
  • a new lump in a relevant nodal basin;
  • new nerve-type pain, numbness or tingling near the previous tumour.

When imaging matters

Routine CT is not needed after typical low-risk BCC. In cSCC with substantial metastatic risk, imaging may be part of staging and early surveillance.

cSCC 2026 - imaging is risk-adapted

The international consensus supports considering staging/surveillance imaging when estimated metastatic risk is approximately 15% or higher. CT was the preferred modality for nodal staging and surveillance in the consensus; selected high-risk patients reached consensus for imaging surveillance for at least 2 years. Ultrasound remains useful for accessible superficial nodal basins and targeted assessment.

2026 imaging consensus.

Preventing another skin cancer

Avoid sunburn, do not use tanning beds, combine shade and protective clothing with broad-spectrum sunscreen, and continue regular self-examination for new or changing lesions.